Axios - The U.S. leads the world in pharmaceutical innovation. But experts say the whole ecosystem is under threat, which could ultimately result in fewer breakthrough treatments. Cuts to NIH funding will make it harder to get new research started, they say. Cuts and policy changes at the FDA threaten to make the finish line less predictable.
RFK Jr., the HHS secretary, has talked about scrapping the process the FDA uses to decide whether to approve new drugs, calling it a conflict of interest because it's funded heavily by the industry. That would be "catastrophic," one former FDA official told Axios. More
No comments:
Post a Comment